Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) in 4 major cities in the United States.

IF 5.6 2区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Hepatology Communications Pub Date : 2025-05-06 eCollection Date: 2025-05-01 DOI:10.1097/HC9.0000000000000704

Jeffrey V Lazarus, Trenton M White, Alina M Allen, Silvana Pannain, Naim Alkhouri, Meena B Bansal, Michael Charlton, Brett E Fortune, Yehuda Handelsman, Scott Isaacs, Ira M Jacobson, Sonal Kumar, Melina I Manolas, Mazen Noureddin, Mary E Rinella, Norah Terrault, Ayman El-Mohandes

引用次数: 0

Abstract Image

查看原文本刊更多论文

美国4个主要城市对代谢功能障碍相关脂肪变性肝病（MASLD）的认识

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Hepatology Communications GASTROENTEROLOGY & HEPATOLOGY-

CiteScore

8.00

自引率

2.00%

发文量

248

审稿时长

8 weeks

期刊介绍： Hepatology Communications is a peer-reviewed, online-only, open access journal for fast dissemination of high quality basic, translational, and clinical research in hepatology. Hepatology Communications maintains high standard and rigorous peer review. Because of its open access nature, authors retain the copyright to their works, all articles are immediately available and free to read and share, and it is fully compliant with funder and institutional mandates. The journal is committed to fast publication and author satisfaction.